National Guideline Clearinghouse | New antiretroviral drugs: maraviroc, raltegravir, etravirine, and rilpivirine.

full-text:
National Guideline Clearinghouse | New antiretroviral drugs: maraviroc, raltegravir, etravirine, and rilpivirine.

Guideline Title

New antiretroviral drugs: maraviroc, raltegravir, etravirine, and rilpivirine.

Bibliographic Source(s)

New York State Department of Health. New antiretroviral drugs: maraviroc, raltegravir, etravirine, and rilpivirine. New York (NY): New York State Department of Health; 2011 Nov. 8 p. [14 references]

Guideline Status

This is the current release of the guideline.
This guideline updates a previous version: New York State Department of Health. New antiretroviral drugs: maraviroc, raltegravir, and etravirine. New York (NY): New York State Department of Health; 2010 Jun. 6 p.